These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18171217)

  • 1. Rapid virologic response: a new milestone in the management of chronic hepatitis C.
    Poordad F; Reddy KR; Martin P
    Clin Infect Dis; 2008 Jan; 46(1):78-84. PubMed ID: 18171217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of naive patients with chronic hepatitis C].
    Vince A; Duvnjak M
    Acta Med Croatica; 2009 Dec; 63(5):409-15. PubMed ID: 20198900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.
    Kessler HH; Pierer K; Santner BI; Vellimedu SK; Stelzl E; Marth E; Fickert P; Stauber RE
    J Hum Virol; 1998; 1(5):314-9. PubMed ID: 10195258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualisation of antiviral therapy for chronic hepatitis C.
    Teoh NC; Farrell GC; Chan HL
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1206-16. PubMed ID: 20594246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C.
    Vermehren J; Yu ML; Monto A; Yao JD; Anderson C; Bertuzis R; Schneider G; Sarrazin C
    J Clin Virol; 2011 Oct; 52(2):133-7. PubMed ID: 21803650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C virus management: 2000-2005 update.
    Hughes CA; Shafran SD
    Ann Pharmacother; 2006 Jan; 40(1):74-82. PubMed ID: 16368925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and accurate prediction of Peg-IFNs/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells.
    Colombatto P; Ciccorossi P; Maina AM; Civitano L; Oliveri F; Coco B; Romagnoli V; Bonino F; Brunetto MR
    Clin Pharmacol Ther; 2008 Aug; 84(2):212-5. PubMed ID: 18388885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and therapeutic implications of hepatitis C virus compartmentalization.
    Di Liberto G; Roque-Afonso AM; Kara R; Ducoulombier D; Fallot G; Samuel D; Feray C
    Gastroenterology; 2006 Jul; 131(1):76-84. PubMed ID: 16831592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological relapse in chronic hepatitis C.
    Poordad FF; Flamm SL
    Antivir Ther; 2009; 14(3):303-13. PubMed ID: 19474464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of response to therapy for chronic hepatitis C.
    Ferenci P
    Semin Liver Dis; 2004; 24 Suppl 2():25-31. PubMed ID: 15346243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus kinetics.
    Herrmann E; Neumann AU; Schmidt JM; Zeuzem S
    Antivir Ther; 2000 Jun; 5(2):85-90. PubMed ID: 10971860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
    Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
    Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C.
    Chevaliez S; Pawlotsky JM
    J Viral Hepat; 2007 Nov; 14 Suppl 1():77-81. PubMed ID: 17958647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Easy to treat' genotypes were not created equal: can rapid virological response (RVR) level the playing field?
    Duarte-Rojo A; Heathcote EJ; Feld JJ
    J Hepatol; 2011 Aug; 55(2):466-73. PubMed ID: 21334393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon-alpha.
    Antonelli G; Riva E; Maggi F; Vatteroni ML; Simeoni E
    J Infect Dis; 1999 Oct; 180(4):1411-2. PubMed ID: 10479188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.